Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Plans Crackdown On Drug Maker Unfair Margins

This article was originally published in PharmAsia News

Executive Summary

Drug makers who charge wholesalers and pharmacists more than what is considered the government's "fair margin" could be fined the difference. The ministry of chemicals and fertilizers is considering a plan to make every company involved in the chain of getting a drug from manufacturer to patient to disclose the margins pharmaceutical firms offer outside of price controls at each level. The ministry estimates 75 percent of the retail market consists of such drugs. The plan also includes creation of trade margin caps as a percentage of retail prices. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel